Q3 net sales increased 4% from the prior year; orders were up 2%; on an organic basis, sales increased 6% and orders increased 3% over prior year

Gross margin in Q3 improved 180 bps from the prior year due to lower commodity costs, favorable product mix and operational improvements.

EPS in Q3 totaled $0.46 per share, a 24% increase over last year in adjusted EPS.

$162 $162$169 $164

$50

$70

$90

$110

$130

$150

$170

$190

Q4 FY15

Q1 FY16

Q2 FY16

Q3 FY16

$200

$300

$400

$500

$600

$700

Q4 FY15 Q1 FY16 Q2 FY16 Q3 FY16

$551 $565 $580$537$557 $563

$601

$509

Quarterly Net Sales + Orders($ millions)

Quarterly Operating Expenses($ millions)

Net Sales Orders

38.1% 38.3% 38.7% 38.7%

0.0%

10.0%

20.0%

30.0%

40.0%

50.0%

Gross Margin %Adjusted Operating Income %

Gross Margin and Adjusted Operating Margin(% net sales)

8.7% 9.7% 9.6% 8.3%

Q4 FY15 Q3 FY16Q2 FY16Q1 FY16

Q3 ending cash and equivalents totaled $55.0 million, consistent with Q2.

LT Debt maturity schedule:

– PPN ($150M) due 2018– Revolver ($57M) due 2019– PPN ($50M) due 2021

Availability of $201 million on the revolving line of credit at the end of Q3.

CAPEX totaled $55 million through Q3. Expecting $70 - $80 million for fiscal 2016.

Dividends paid in Q3 totaled $8.8 million

Quarterly Cash Flow from Operations($ millions)

Q4 FY15

Q1 FY16

Q2 FY16

Q3 FY16

$58

$33$40

$53

$0

$10

$20

$30

$40

$50

$60

Q4 FY15

Q1 FY16

Q2 FY16

Q3 FY16

Rolling 4 Qtr Coverage Ratio(EBITDA(1) to Interest)

Rolling 4 Qtr Leverage Ratio(Debt to EBITDA)(1)

(1) Represents a Non-GAAP Measure, see Appendix for reconciliation.

13.415.0

16.3 17.3

0.02.04.06.08.0

10.012.014.016.0

Bank Covenant > 4.0

1.3 1.1 1.0 0.9

0.0

0.5

1.0

1.5

2.0

2.5

3.0

3.5

4.0 Bank Covenant < 3.5

Q4 FY15

Q1 FY16

Q2 FY16

Q3 FY16

Q4 Fiscal 2016

Net Sales $560 to $580 million

Gross Margin % 38.0% to 39.0%

Operating Expenses* $165 to $169 million

Effective Tax Rate* 28% to 30%(31% to 33% excluding gain)

Earnings Per Share, Diluted* $0.57 to $0.61

* Reflects the impact of a $3.5 million ($0.06 per share) net gain related primarily to the sale of a former UK manufacturing facility.

Guidance as provided in March 16, 2016 earnings press release:

Adjusted EBITDA (Bank) RatiosTrailing 4-Quarter Period EndedQ4 FY15 Q1 FY16 Q2 FY16 Q3 FY16

Earnings Before Income Taxes (EBT) 145.2 158.5 168.5 176.3 Add: Depreciation 44.2 45.6 46.2 45.0 Amortization 5.6 5.9 6.0 6.1 Interest 17.5 16.7 16.0 15.3 Other Adjustments (1) 22.7 23.7 23.6 21.9 Adjusted EBITDA - Bank 235.2$ 250.4$ 260.3$ 264.6$

Total Debt, End of Trailing Period (includes outstanding LC's) 298.3$ 279.1$ 266.0$ 249.6$

Rolling 4-Quarter Debt-to-Adj. EBITDA 1.3 1.1 1.0 0.9

Rolling 4-Quarter Adj. EBITDA-to-Interest 13.4 15.0 16.3 17.3

(1) "Other Adjustments" include, as applicable in the period, charges associated w ith business restructuring actions, non-cash stock-based compensation, as defubed in lending agreements.